China News Service, March 16 (Reporter Chen Jing) Professor Huo Yong, vice chairman of the China Cardiovascular Health Alliance, advocated the implementation of "three highs" ("three highs" refers to high blood pressure, high blood pressure, Blood sugar and hyperlipidemia), that is, from the government to medical institutions to society and the public, the implementation must be promoted at various levels to form a coordinated management of cardiovascular disease incidence and death risk factors, and establish a new type of chronic disease management system.
For a long time, the morbidity and mortality of cardiovascular diseases in China have continued to rise.
As a well-known cardiologist, Professor Yong Huo said bluntly that the most important reason is that with the development of society and economy and changes in lifestyle, cardiovascular disease risk factors are prevalent, and the control of these risk factors still exists "short-term". board".
Huo Yong said that the prevention and treatment of cardiovascular diseases should focus on the whole of China, focus on the public, and the whole society should pay attention to it, and promote the "turning point" of the decline in the incidence and mortality of cardiovascular diseases.
How to speed up the prevention and treatment of cardiovascular diseases?
In an interview with reporters on the same day, Huo Yong said: "Combining with the successful experience of reducing the incidence and death of cardiovascular and cerebrovascular diseases at the national level in the world, on the one hand, we must take precautions and control blood pressure, blood lipids, blood sugar and other factors; on the other hand; It is necessary to improve the level of treatment and reduce the risk of death of patients through effective treatment in the acute phase of the disease."
Huo Yong said bluntly: "In recent years, public health has achieved remarkable results in the management and control of hypertension and diabetes, but blood lipid management is still the shortcoming of the current'three-high management', and screening, treatment and management are relatively weak." He pointed out that in the future. The "three-high co-management" is an inevitable trend, and believes that on the basis of the management of hypertension and hyperglycemia, including blood lipid management into the existing national basic public health services will greatly improve the prevention and control efficiency of cardiovascular and cerebrovascular diseases, and effectively reduce Management costs will play an important role in reducing the incidence, recurrence and mortality of cardiovascular diseases.
In an interview, Huo Yong said frankly that the current situation of chronic diseases in China is not optimistic, and the chronic disease prevention and management system is still inadequate.
"Medical institutions are the main force in the prevention and treatment of chronic diseases, and they need to rely on the construction of medical consortiums, give full play to the advantages of professional resources of medical institutions, and achieve'governance linkage'. At the same time, strengthen information construction and use the Internet and telemedicine to improve Basic-level treatment capabilities".
In terms of medical insurance payment system and drug innovation, Huo Yong suggested that medical insurance should not only better promote disease prevention and control, but also promote system construction.
"Not only how to treat in the hospital, but also how to manage the follow-up." The vice chairman of the China Cardiovascular Health Alliance believes that future disease management should also stimulate the integration of various social resources such as commercial insurance. Further guarantee the improvement of the level of chronic disease management protection; at the same time, on the basis of optimizing the structure of chronic disease-related basic drugs and guiding clinical rational use of drugs, actively encourage the approval and clinical application of innovative drugs, according to the characteristics of patients’ long-term disease changes, and pertinence Adjust the drug treatment plan accordingly.
The expert explained with an example of hypertension, the most important risk factor for cardiovascular diseases, that the treatment model should be based on lowering blood pressure and pay more attention to the protection of target organs to further reduce the risk of cardiovascular events.
(Finish)